News of Pharmaceuticals | Healthcare | Wellness in Gujarat

#DLGGujaratConnect | VIAGRA Manufacturer – “Pfizer” shuts Aurangabad & Chennai units in India, impacting 1,700 jobs

MUMBAI | AURANGABAD | CHENNAI | NEW DELHI | AHMEDABAD | RAJKOT –  Following a thorough evaluation of the Aurangabad (Maharashtra) and Irungattukottai (Tamilnadu) plant, Pfizer Ltd has finally decided to shutdown the two facilities in India, on grounds of long-term loss of product demand, making manufacturing at this sites “unviable”, the three page handout

Zydus Cadila gets USFDA nod to market drugs to treat cholesterol and body tissues

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having got US Food & Drugs Administration’s nod to market drug two drugs, one to control cholesterol as well another to treat abnormal hardening

Zydus Cadila gets USFDA nod to market drug to treat excess iron levels in human blood

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Exchanges on Tuesday, Ahmedabad headquartered and Pankaj Patel owned Cadila Healthcare (Zydus Cadila Group) said of having got US Food and Drugs Administration nod to market drug to treat excess iron levels in human blood. Zydus Cadila has received the tentative

Alembic Pharma gets USFDA nod to market erectile dysfunction treatment drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India on Tuesday, Alembic Pharma said of having got approval from US Food & Drugs Administration to market erectile dysfunction treatment tablets, the product has an estimated market-size of US $ 8 million over period of 12 months. Alembic

US FDA issues form 483 to Alembic Pharma’s Panelav facility for oral solids

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update filed to the Indian Bourses on Friday, Alembic Pharmaceuticals Ltd said of having got their Panelav facility manufacturing general oral solids inspected by US FDA (Food & Drugs Administration) and the regulator having slammed Form 483 to the facility, after inspection. The United States

Zydus Cadila gets US FDA nod to market drug for treatment of epilepsy

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Cadila Healthcare Ltd (Dr Pankaj Patel owned Zydus Cadila group) said of having availed regulatory approval from US Food and Drugs Administration (USFDA) to market drug to treat epilepsy. Zydus Cadila has received the final approval from the

USFDA successfully inspects Alembic’s JV facility Aleor Derma

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India on Monday, in wee hours before the trading session kicked-off on the Indian Bourses, Alembic Pharmaceuticals Ltd said of Aleor Dermaceuticals Ltd’s facility, getting successfully inspected by USFDA. Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic

Zydus Cadila gets US FDA nod to market anti-arthritis drug

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Bourses on Thursday, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having received regulatory approvals from US FDA (Food & Drugs Department) to market anti-arthritis drug. Zydus Cadila has received the tentative approval from

Zydus Cadila gets US FDA nod to market skin-care ointment

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the exchanges in India on Wednesday, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market skin-care ointment. Zydus Cadila has received the final approval from the USFDA to

Alembic gets US FDA nod to market diet-exercise equivalent pill, for diabetics

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted on Tuesday, Vadodara headquartered and Amin family owned Alembic Pharma said of having got approval from US FDA (Food & Drugs Administration) to market diet and exercise equivalent pill for diabetic patients. Alembic Pharmaceuticals Limited today announced that the company has received tentative

Lincoln Pharma invests in renewable energy assets to save on energy cost

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Bourses on Monday, Ahmedabad headquartered Lincoln Pharmaceuticals Ltd said of having invested in renewable energy assets to save on energy cost and improve financials, as well having applied for permission to set-up Active Pharmaceuticals Ingredients (API) manufacturing unit. The Company has

Zydus Biologics (of Zydus Cadila Group) inspected successfully by US FDA

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Bourses, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of one of the company’s subsidiary facilities being inspected successfully by US Food & Drug Administration. The Company’s Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in

Maruti Suzuki partners with Zydus Hospitals, sets up modern polyclinic

BECHARAJI (HANSALPUR) | MEHSANA | AHMEDABAD | NEW DELHI | MUMBAI | RAJKOT – In a press-release submitted to the exchanges in India on Wednesday, Maruti Suzuki India Ltd said of having partnered with Zydus Hospitals to set-up a modern polyclinic (health centre) facility at Becharaji, vide corporate social responsibility initiative. Access to quality and

Zydus Cadila gets US FDA nod to market osteoporosis, ortho treatment drug

MUMBAI | AHMEDABAD | RAJKOT – Dr Pankaj Patel led and Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) has received final approval from the US regulators to market ortho treatment medicine, the company said in a press release submitted to the Indian Bourses, today. Zydus Cadila has received the final approval from the USFDA

Zydus Cadila keen to set-up mfg facility at Hyderabad, reports Telangana Today

HYDERABAD | AHMEDABAD | RAJKOT – Ahmedabad headquartered and Dr Pankaj Patel led Zydus Cadila Group (Cadila Healthcare Ltd) is keen to establish setting-up a facility in the upcoming Hyderabad Pharma City, Telengana Today reports Quoting Dr Pankaj Patel as told to Telengana Today, the report said of Cadila Healthcare in future to surely look

Zydus Cadila gets US FDA nod to market tablets for diabetic care

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Dr Pankaj Patel led Zydus Cadila group (Cadila Healthcare Ltd.) said of having got approval from US FDA (Food & Drugs Administration) to market Sitagliptin Tablets in dosage value of 25 mg (milligram), 50 mg and 100 mg.